Risk-reducing salpingo-oophorectomy (RRSO) is the most effective intervention for reducing ovarian cancer risk in women with hereditary breast and ovarian cancer syndrome (HBOC) associated with pathogenic <i>BRCA1</i> and <i>BRCA2</i> variants. The gene discussed is BRCA2; the disease is hereditary breast ovarian cancer syndrome.